Guilin Pharmaceutical Co., Ltd. | Company Profile - Revenue, Headcount, Tech Stack, Contacts

Founded in 1958 and headquartered in Guilin, Guangxi, China, this leading pharmaceutical company specializes in the research, development, production, and marketing of chemical drugs. As a subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. since 2003, the company is recognized as the world's largest manufacturer of artemisinin-based products, having supplied over 100 million doses of Artesunate to malaria-endemic areas since 2006.

With a focus on off-patent generics, active pharmaceutical ingredients (APIs), and antimalarials, the company's product range includes anti-malarials such as Artesunate and Artemether, alongside various antibiotics and other generics produced in WHO GMP-certified workshops. Its commitment to quality is demonstrated by multiple WHO-prequalified products and facilities regularly inspected by international health authorities. Products are supplied to organizations including WHO, UNICEF, and MSF, serving global markets, especially developing countries.